AU Content in the MicroRNA Sequence Influences its Stability after Heat Treatment

Author(s): Agnès Garcias López, Louise Brogaard, Peter Mikail Helwag Heegaard, Susanna Cirera, Kerstin Skovgaard*.

Journal Name: MicroRNA

Volume 8 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: MicroRNAs (miRNAs) are short non-coding RNA molecules which regulate gene expression post-transcriptionally and are involved in a multitude of cellular processes. MiRNAs are known to be very stable compared to messenger RNAs (mRNAs), making them excellent candidates as biomarkers for disease. Recently, studies have suggested that miRNA stability in formalin fixed samples might depend on their nucleotide composition.

Objective: To explore the stability of a panel of miRNAs isolated from porcine blood and lung tissue after heat and enzyme treatment.

Method: Porcine RNA isolated from lung tissue and blood leukocytes was used for this study. RNA samples were exposed to heat treatment and RNAse A digestion. The levels of selected miRNAs were measured by means of qPCR before and after heat and enzyme treatment.

Results: Fourteen miRNAs were successfully analysed, and they were found to degrade differently after exposure to heat or RNAse A. MiRNAs with <60% of adenine (A) and uracil (U) in their sequence were found to be more stable.

Conclusion: This is the first study showing that different miRNAs isolated from lung tissue display unequal stability after heat treatment, probably based on their nucleotide composition, highlighting the importance of considering the miRNA sequence when investigating their value as biomarkers.

Keywords: % AU, heat treatment, miRNA, RNAse A digestion, stability, saliva.

[1]
Tüfekci KU, Meuwissen RL, Genç S. The role of microRNAs in biological processes. Methods Mol Biol 2014; 1107: 15-31.
[2]
Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol 2016; 231(1): 25-30.
[3]
Aryani A, Denecke B. In vitro application of ribonucleases: comparison of the effects on mRNA and miRNA stability. BMC Res Notes 2015; 8(1): 164.
[4]
Zhang Z, Qin YW, Brewer G, Jing Q. MicroRNA degradation and turnover: regulating the regulators. Wiley Interdiscip Rev RNA 2012; 3(4): 593-600.
[5]
Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 2014; 3
[http://dx.doi.org/10.3402/jev.v3.23743]
[6]
Arroyo J, Chevillet J, Kroh E, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-8.
[7]
Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13: 423-33.
[8]
Yamada A, Cox M, Gaffney K, Moreland A, Boland CR, Goel A. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS One 2014; 9(11): e112481.
[9]
Glinge C, Glinge C, Clauss S, et al. Stability of circulating blood-based microRNAs-pre-analytic methodological considerations. PLoS One 2017; 12(2): e0167969.
[10]
Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 2009; 390(1): 1-4.
[11]
Balzano F, Deiana M, Dei Giudici S, et al. MiRNA stability in frozen plasma samples. Molecules 2015; 20(10): 19030-40.
[12]
Kakimoto Y, Tanaka M, Kamiguchi H, Ochiai E, Osawa M. MicroRNA stability in FFPE tissue samples: dependence on GC content. PLoS One 2016; 11(9): e0163125.
[13]
Tan GW, Khoo ASB, Tan LP. Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs. Sci Rep 2015; 5: 9430.
[14]
Jung M, Schaefer A, Steiner I, et al. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 2010; 56(6): 998-1006.
[15]
Enelund L, Nilesen LN, Cirera S. Evaluation of microRNA stability in plasma and serum from healthy dogs. MicroRNA 2017; 6(1): 42-52.
[16]
Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex. Neurosci Lett 2009; 459(2): 100-4.
[17]
Brogaard L, Heegaard PM, Larsen LE, et al. Late regulation of immune genes and microRNAs in circulating leukocytes in a pig model of influenza A (H1N2) infection. Sci Rep 2016; 6: 21812.
[18]
Skovgaard K, Cirera S, Vasby D, et al. Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2). Innate Immun 2013; 19(5): 531-44.
[19]
Balcells I, Cirera S, Busk PK. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol 2011; 11(1): 70.
[20]
Busk PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics 2014; 15: 1-9.
[21]
Cirera S, Busk PK. Quantification of miRNAs by a simple and specific qPCR method. In: Alvarez ML, Nourbakhsh M, editors.RNA mapping: methods and protocols. USA: Humana Press, Springer 2014; pp. 73-81.
[22]
Brogaard L, Larsen LE, Heegaard PM, et al. IFN-λ and microRNAs are important modulators of the pulmonary innate immune response against influenza A (H1N2) infection in pigs. PLoS One 2018; 13(4): e0194765.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 3
Year: 2019
Page: [216 - 222]
Pages: 7
DOI: 10.2174/2211536608666190131102252
Price: $58

Article Metrics

PDF: 42
HTML: 5